CUV

CLINUVEL PHARMACEUT.

12.64

0.000.00%

Closed16:10 01/09 AEDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE12.60/12.64

TODAY RANGE12.54-12.78

VOL58.88K

MARKET CAP634.54M

52 WEEK RANGE9.41-14.00

AVG VOL (3M)100.86K

% TURNOVER0.10%

TURNOVER746.42K

P/E (TTM)17.60

% RANGE1.90%

EPS(TTM)0.718

P/E(FORWARD)16.99

P/B2.631

BVPS4.804

DIVIDEND0.050

P/S6.67

BETA--

DIV YIELD0.40%

FREE FLOAT MKT CAP528.80M

SHARES OUTSTANDING50.20M

NEXT EARNINGS02/25-03/02

FREE FLOAT41.84M

LOT SIZE1

EX-DATE09/04/2025

News

Press Releases

Financial Reports

Profile

ASX·2d ago
SCENESSE efficacy in vitiligo - new cases presented at RDTC
ASX·01/01 22:24
Notification of cessation of securities - CUV
ASX·12/18/2025 21:35
CLINUVEL progresses Level II ADR upgrade, Nasdaq uplist
The Motley Fool·12/08/2025 02:57
Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today
ASX·12/07/2025 21:35
CLINUVEL expands Singapore RD&I Centre
Dow Jones·12/04/2025 21:10
*Clinuvel Pharmaceuticals Price Target Raised 12% to A$41.85/Share by Jefferies
ASX·12/01/2025 23:39
CLINUVEL advances NEURACTHEL Instant, EU filing mid-2026
ASX·11/13/2025 21:28
Stifel Healthcare Conference presentation
Dow Jones·11/11/2025 23:05
*Clinuvel Pharmaceuticals Raised to Spec Buy From Hold by Morgans >CUV.AU
ASX·11/11/2025 21:32
Change in substantial holding
ASX·11/02/2025 22:52
Update on ADR upgrade, Nasdaq uplisting
ASX·10/17/2025 02:01
Results of Meeting
ASX·10/17/2025 01:57
Managing Director Address
ASX·10/16/2025 23:05
Chair address
ASX·10/16/2025 01:45
Health Canada requests additional time for SCENESSE review

Same Industry

Name/Symbol

Change%

Price

No data yet, let's see others

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.